Back to search results

The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study

This study, called "The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study," is looking at how different ways of organizing heart care during pregnancy affect the health of both mothers and babies. Researchers want to understand what works best for pregnant people with existing heart conditions. They will observe 1000 pregnant individuals with heart disease, including conditions like congenital heart disease, arrhythmias, or heart failure. The main goal is to see how often adverse pregnancy outcomes (problems during or after pregnancy) occur up to six weeks after birth. This study is currently observing participants.

Study design
This is an observational study involving 1000 pregnant individuals. It is not testing a new treatment but rather observing current care and outcomes.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed up to 6 weeks postpartum to measure adverse pregnancy outcomes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06517628

The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study

Recruiting
Not specifiedAges 18+Observational
University of Missouri, Kansas City
~1,000 participants
Updated 2025-01-20 on ClinicalTrials.gov
What's tested:Purely observational study on the care and outcomes of participants with cardiovascular disease in pregnancy.

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Rate of Adverse pregnancy outcomes
Measured over up to 6 weeks postpartum

Conditions

Pregnancy Complications, Cardiovascular

Explore related trials

ArrhythmiaArthropathyCardiomyopathyCongenital Heart DiseaseCoronary Artery DiseaseEndocarditisHeart FailurePericardial ConstrictionPericardial EffusionPericarditisPulmonary HypertensionStructural Heart Disease

Where it's being run

1 sites across 1 states
Missouri1

Study leadership

  • John Spertus, MD, MPH · PRINCIPAL_INVESTIGATOR · University of Missouri, Kansas City

Who to contact

Karen L Florio, DO, MPH
[email protected]
631-579-1030
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Unable to participate in telephone follow-up
Too hard of hearing to do follow-up by telephone or deaf
Incarcerated prisoner
History of dementia.
Subjects without a way for contact by telephone for follow-up
Refused participation in the study
Unable to consent for self
Traumatic Aortic Disease
Peripartum cardiomyopathy diagnosed in current pregnancy

What this trial measures

  • Rate of Adverse pregnancy outcomesup to 6 weeks postpartum

    HELLP, preeclampsia, gestational hypertension, eclampsia, superimposed preeclampsia on chronic hypertension (SIPE), premature preterm rupture of membranes (PPROM), preterm delivery, thrombotic complications, hemorrhage, maternal mortality, placental abruption, Admission ICU delivery